Gut microbiome

Description

Gut Microbiome Mapping (GI-MAP) is an advanced gut health test designed to give patients a clearer understanding of their digestive and intestinal health. This test evaluates more than 100 gut health markers, including important indicators such as Zonulin, SCFAs, and Calprotectin.

The gut microbiome plays an important role in digestion, nutrient absorption, immune function, inflammation, and overall wellness. An imbalance in gut bacteria or signs of intestinal inflammation may contribute to symptoms such as bloating, irregular bowel movements, abdominal discomfort, food sensitivity, fatigue, or poor digestion.

This test helps assess the balance of beneficial and harmful microorganisms in the gut, while also checking key markers related to intestinal barrier function and inflammation. Zonulin is commonly associated with gut barrier health, SCFAs are important compounds produced by beneficial gut bacteria, and Calprotectin is a marker that may indicate intestinal inflammation.

Gut Microbiome Mapping may be suitable for patients who want to investigate ongoing digestive symptoms, monitor gut health, or better understand how their microbiome may be affecting their overall wellbeing. The results can help doctors or healthcare providers recommend more personalized next steps, such as diet changes, lifestyle support, probiotics, or further medical evaluation when needed.

Results are usually available within 14–16 days. This test provides useful insight into gut function and microbiome balance, but it should be interpreted together with the patient’s symptoms, medical history, and professional medical advice.

Important: This test is for health screening and assessment purposes. It is not a replacement for medical consultation, diagnosis, or treatment. Patients with severe, persistent, or worsening symptoms should consult a doctor.